AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience’s Mika Salpeter Lifetime Achievement Award
BALTIMORE, MARYLAND—AgeneBio, a pharmaceutical company developing innovative therapeutics that prevent neurodegeneration and preserve and restore brain function, today announced that the Company’s founder and chief scientific officer Michela Gallagher, PhD, has received the Society for Neuroscience’s Mika Salpeter Lifetime Achievement…